Sara James
Interventional Pain Medicine · Champaign, ILNPI 1558895862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Boston Scientific at 29.5% of the total. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 43 payments — averaging $37.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$477
- Medtronic$304
- MML US, Inc.$255
- Stryker$185
- Abbott$104
- Nalu Medical, Inc.$101
- plus $191 from 6 others
What the payments were for
- Food & beverage$1,618100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $477 |
| Medtronic | 12 | $304 |
| MML US, Inc. | 4 | $255 |
| Stryker | 3 | $185 |
| Abbott | 4 | $104 |
| Nalu Medical, Inc. | 1 | $101 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Vertos Medical, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $29 |
| AbbVie | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Merck | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,618 in reported general payments places this provider in the 45th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydromorphone Hcl | 17 | $1,475 |
| Gabapentin | 80 | $1,431 |
| Duloxetine Hcl | 59 | $1,189 |
| Pregabalin | 51 | $927 |
| Celecoxib | 18 | $554 |
| Baclofen | 14 | $254 |
| Tizanidine Hcl | 23 | $247 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $184 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Champaign
- Paul NaourChampaign$1K
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.